Molecular Mechanisms of the Myotonic Dystrophy Mutation
Molecular Mechanisms of the Myotonic Dystrophy Mutation
批准号:
8450132
负责人:
Mani Subramaniam Mahadevan
金额:
$30.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-04-09 至 2015-05-31
关键词:
3&apos Untranslated RegionsAblationAddressAdultAffectAllelesBreedingCardiacCell LineConnexin 43DataDefectDiseaseElementsFunctional RNAGenesGenetic TranscriptionGrantGreen Fluorescent ProteinsHeartHereditary DiseaseHistopathologyHumanHuman GeneticsIndividualInternal Ribosome Entry SiteKnock-in MouseKnockout MiceLacZ GenesLuciferasesMessenger RNAMicrosatellite RepeatsMitoticModelingMolecularMusMuscleMuscular DystrophiesMutationMyoblastsMyocardiumMyotoniaMyotonic DystrophyNuclearNuclear InclusionNucleic Acid Regulatory SequencesPathologyPhenotypeProteinsRNARNA SplicingRNA-Binding ProteinsReporterReporter GenesReportingRoleSkeletal MuscleTherapeuticTissuesToxic effectToxinTranscriptTranscriptional ActivationTransgenic Miceconnexin 40in vivomouse modelmutantmyotonic dystrophy protein kinasenoveloffspringoverexpressionpromoterresponsetranscription factortransgene expressionwasting
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Myotonic dystrophy (DM1), the most common muscular dystrophy in adults, is caused by an expanded (CTG)n
tract in the 3' untranslated region (3'UTR) of the DM protein kinase (DMPK) gene resulting in nuclear
entrapment of the "toxic" mutant RNA and interacting RNA-binding proteins (e.g. MBNL1) in ribonuclear
inclusions. To address this, we generated transgenic mice expressing the DMPK 3'UTR as part of an inducible
RNA transcript encoding green fluorescent protein (GFP) (ref). Surprisingly, we found that mice
overexpressing a normal DMPK 3'UTR mRNA reproduced cardinal features of DM including myotonia, cardiac
conduction abnormalities, DM histopathology and RNA splicing defects in the absence of detectable nuclear
inclusions. Importantly, these effects were reversible in both mature skeletal and cardiac muscles by silencing
transgene expression. These results represented the first in vivo proof of principle for a therapeutic strategy to
treat DM through ablation of the toxic RNA or silencing its expression. Using this model, we have started to
study the cardiac conduction defects. We have now found evidence for an unanticipated mechanism for key
aspects of DM1. Transgene expression resulted in cardiac conduction defects exactly like those in DM,
aberrant expression of the cardiac transcription factor Nkx2.5, and profound disturbances in connexin 40
(Cx40) and connexin 43 (Cx43), proteins that are targets of Nkx2.5 and crucial for normal cardiac conduction.
In skeletal muscle, over-expression of the DMPK 3'UTR mRNA also unexpectedly induced transcriptional
activation of Nkx2.5, normally a cardiac transcription factor postnatally. Our results suggest that expression of
the DMPK 3'UTR mRNA induces Nkx2.5 transcription, by as yet unknown mechanisms. To study this further,
the aims of this proposal are to understand the role of Nkx2.5 in modulating the DM1 phenotype, to create a
transgenic mouse model of Nkx2.5 expression and to attempt to understand how the DMPK 3'UTR mRNA
transcriptionally activates the Nkx2.5 gene.
Myotonic dystrophy is the most common muscular dystrophy in adults. It is thought to be caused by a toxic
RNA. We have developed a mouse model of RNA toxicity and hope that with these studies we may be able to
understand how this toxic RNA causes DM, so that we can contemplate strategies for new therapies.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1083/jcb.200206020
发表时间:
2002-11-11
期刊:
The Journal of cell biology
影响因子:
--
作者:
[Amack JD, Reagan SR, Mahadevan MS]
通讯作者:
Mahadevan MS
DOI:
10.1083/jcb.201108113
发表时间:
2012-03-19
期刊:
The Journal of cell biology
影响因子:
--
作者:
[Ravel-Chapuis A, Bélanger G, Yadava RS, Mahadevan MS, DesGroseillers L, Côté J, Jasmin BJ]
通讯作者:
Jasmin BJ
DOI:
10.1002/mus.22090
发表时间:
2011-08
期刊:
MUSCLE & NERVE
影响因子:
3.4
作者:
[Foff, Erin Pennock, Mahadevan, Mani S.]
通讯作者:
Mahadevan, Mani S.
DOI:
10.1093/hmg/ddu617
发表时间:
2015-04
期刊:
Human molecular genetics
影响因子:
3.5
作者:
[R. S. Yadava;Erin P. Foff;Qing Yu;J. Gladman;Y. Kim;K. Bhatt;C. Thornton;T. Zheng;M. Mahadevan]
通讯作者:
R. S. Yadava;Erin P. Foff;Qing Yu;J. Gladman;Y. Kim;K. Bhatt;C. Thornton;T. Zheng;M. Mahadevan
Disease Phenotypes in a Mouse Model of RNA Toxicity Are Independent of Protein Kinase Cα and Protein Kinase Cβ.
RNA 毒性小鼠模型中的疾病表型与蛋白激酶 Cα 和蛋白激酶 Cβ 无关。
DOI:
10.1371/journal.pone.0163325
发表时间:
2016
期刊:
PloS one
影响因子:
3.7
作者:
[Kim,YunK, Yadava,RameshS, Mandal,Mahua, Mahadevan,Karunasai, Yu,Qing, Leitges,Michael, Mahadevan,ManiS]
通讯作者:
Mahadevan,ManiS
共 9 条
The role of TGFβs and cFAPs in Cardiac Pathology from RNA Toxicity
-
批准号:10717904
-
项目类别:
-
资助金额:$80.7万
-
财政年份:2023
-
负责人:Mani Subramaniam Mahadevan
-
依托单位:
RNA Toxicity and Cardiac Pathology
-
批准号:10705364
-
项目类别:
-
资助金额:$75.5万
-
财政年份:2022
-
负责人:Mani Subramaniam Mahadevan
-
依托单位:
RNA Toxicity and Muscle Regeneration
-
批准号:9252112
-
项目类别:
-
资助金额:$39.28万
-
财政年份:2017
-
负责人:Mani Subramaniam Mahadevan
-
依托单位:
Role of FN14 in RNA Toxicity
-
批准号:8331374
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2011
-
负责人:Mani Subramaniam Mahadevan
-
依托单位:
Role of FN14 in RNA Toxicity
-
批准号:8517588
-
项目类别:
-
资助金额:$32.92万
-
财政年份:2011
-
负责人:Mani Subramaniam Mahadevan
-
依托单位:
Role of FN14 in RNA Toxicity
-
批准号:8704879
-
项目类别:
-
资助金额:$33.96万
-
财政年份:2011
-
负责人:Mani Subramaniam Mahadevan
-
依托单位:
Role of FN14 in RNA Toxicity
-
批准号:8222504
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2011
-
负责人:Mani Subramaniam Mahadevan
-
依托单位:
Inducible Transgenic Mouse Model of RNA Toxicity
-
批准号:7483165
-
项目类别:
-
资助金额:$30.97万
-
财政年份:2005
-
负责人:Mani Subramaniam Mahadevan
-
依托单位:
Inducible Transgenic Mouse Model of RNA Toxicity
-
批准号:6959625
-
项目类别:
-
资助金额:$33.51万
-
财政年份:2005
-
负责人:Mani Subramaniam Mahadevan
-
依托单位:
Inducible Transgenic Mouse Model of RNA Toxicity
-
批准号:7277768
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2005
-
负责人:Mani Subramaniam Mahadevan
-
依托单位:
Inducible Transgenic Mouse Model of RNA Toxicity
-
批准号:7116873
-
项目类别:
-
资助金额:$32.55万
-
财政年份:2005
-
负责人:Mani Subramaniam Mahadevan
-
依托单位:
Inducible Transgenic Mouse Model of RNA Toxicity
-
批准号:7669244
-
项目类别:
-
资助金额:$30.97万
-
财政年份:2005
-
负责人:Mani Subramaniam Mahadevan
-
依托单位:
MOLECULAR MECHANISMS OF THE MYOTONIC DYSTROPHY MUTATION
-
批准号:6171326
-
项目类别:
-
资助金额:$26.51万
-
财政年份:1999
-
负责人:Mani Subramaniam Mahadevan
-
依托单位:
Molecular Mechanisms of the Myotonic Dystrophy Mutation
-
批准号:8240384
-
项目类别:
-
资助金额:$32.4万
-
财政年份:1999
-
负责人:Mani Subramaniam Mahadevan
-
依托单位:
MOLECULAR MECHANISMS OF THE MYOTONIC DYSTROPHY MUTATION
-
批准号:6632660
-
项目类别:
-
资助金额:$28.13万
-
财政年份:1999
-
负责人:Mani Subramaniam Mahadevan
-
依托单位:
Molecular Mechanisms of the Myotonic Dystrophy Mutation
-
批准号:7870307
-
项目类别:
-
资助金额:$33.75万
-
财政年份:1999
-
负责人:Mani Subramaniam Mahadevan
-
依托单位:
Molecular Mechanisms of the Myotonic Dystrophy Mutation
-
批准号:7654844
-
项目类别:
-
资助金额:$34.09万
-
财政年份:1999
-
负责人:Mani Subramaniam Mahadevan
-
依托单位:
Molecular Mechanisms of the Myotonic Dystrophy Mutation
-
批准号:8050588
-
项目类别:
-
资助金额:$32.4万
-
财政年份:1999
-
负责人:Mani Subramaniam Mahadevan
-
依托单位:
MOLECULAR MECHANISMS OF THE MYOTONIC DYSTROPHY MUTATION
-
批准号:6375209
-
项目类别:
-
资助金额:$27.31万
-
财政年份:1999
-
负责人:Mani Subramaniam Mahadevan
-
依托单位:
MOLECULAR MECHANISMS OF THE MYOTONIC DYSTROPHY MUTATION
-
批准号:6695306
-
项目类别:
-
资助金额:$29.78万
-
财政年份:1999
-
负责人:Mani Subramaniam Mahadevan
-
依托单位:
海外基金